Truist Securities Reiterates Buy on HCA Healthcare, Raises Price Target to $510

Benzinga · 1d ago
Truist Securities analyst David Macdonald reiterates HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $495 to $510.